Target intelligence / Profile preview

Gastrointestinal pathogenic microorganisms

Molecular classification
Other
01

Overview

Gastrointestinal pathogenic microorganisms comprise a diverse group of bacteria, viruses, and parasites that cause enteric diseases by disrupting intestinal homeostasis. Key bacterial pathogens include Salmonella enterica, Escherichia coli, and Clostridioides difficile, while viral agents such as Norovirus and Rotavirus are leading causes of acute gastroenteritis (StatPearls, 2023). These organisms employ various virulence factors, including enterotoxins and adhesion proteins, to colonize the gut mucosa and elicit inflammatory responses (Nature Reviews Microbiology, 2013). Pharmacological intervention typically targets microbial-specific processes, such as cell wall synthesis (beta-lactams) or DNA replication (fluoroquinolones), to eliminate the infection (CDC, 2024). However, the lack of specificity in many current treatments often leads to collateral damage to the host's commensal microbiome, increasing the risk of secondary infections like C. difficile (NIH, 2022). Consequently, drug development is increasingly focused on narrow-spectrum agents and anti-virulence strategies to minimize ecological disruption within the gut (PubMed, 2021).

Other names
Enteric pathogensGut pathogensGastrointestinal microbesGI pathogens
02

Mechanism of action

Antimicrobial agents targeting these microorganisms function by inhibiting essential cellular processes, including cell wall synthesis, protein translation, nucleic acid replication, and metabolic pathways specific to the pathogen.

03

Biological functions

Other
04

Disease associations

InfectionInflammation
05

Safety considerations

Antimicrobial resistanceGut dysbiosisClostridioides difficile-associated diarrheaJarisch-Herxheimer reactionAllergic reactions
06

Interacting drugs

Ciprofloxacin

6 more in the full profile.

07

Biomarkers

Fecal calprotectinStool cultureMultiplex PCR GI panelClostridioides difficile Toxin A/BFecal lactoferrin

Beyond the preview

Go deeper on Gastrointestinal pathogenic microorganisms.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal pathogenic microorganisms.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call